$57.72
1.392.47%
Last update: Nov 11, 7:26 PM
MBX Biosciences Inc (MBX) Stock Price, Quote, News & History
MBXNASDAQ
MBX Biosciences reported one-year canvuparatide data showing sustained calcium control and progress toward a Phase 3 trial.
You can purchase shares of MBX Biosciences (NASDAQ:MBX) through any online brokerage.
Other companies in MBX Biosciences’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
MBX Biosciences has a consensus price target of $71.08.
The stock price for MBX Biosciences (NASDAQ: MBX) is $59 last updated November 11, 2026 at 7:26 PM EST.
There are no upcoming dividends for MBX Biosciences.
MBX Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for MBX Biosciences.
MBX Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision...
